Literature DB >> 25895854

Cognitive and Social Functioning Correlates of Employment Among People with Severe Mental Illness.

Javier Saavedra1, Marcelino López2, Sergio González2, Samuel Arias3, Paul Crawford4.   

Abstract

We assess how social and cognitive functioning is associated to gaining employment for 213 people diagnosed with severe mental illness taking part in employment programs in Andalusia (Spain). We used the Repeatable Battery for the Assessment of Neuropsychological Status and the Social Functioning Scale and conducted two binary logistical regression analyses. Response variables were: having a job or not, in ordinary companies (OCs) and social enterprises, and working in an OC or not. There were two variables with significant adjusted odds ratios for having a job: "attention" and "Educational level". There were five variables with significant odds ratios for having a job in an OC: "Sex", "Educational level", "Attention", "Communication", and "Independence-competence". The study looks at the possible benefits of combining employment with support and social enterprises in employment programs for these people and underlines how both social and cognitive functioning are central to developing employment models.

Entities:  

Keywords:  Cognitive function; Competitive employment; Employment; Serious mental illness; Social firms; Social function

Mesh:

Year:  2015        PMID: 25895854     DOI: 10.1007/s10597-015-9874-4

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  37 in total

1.  RBANS neuropsychological profiles within schizophrenia samples recruited from non-clinical settings.

Authors:  Carmel M Loughland; Terry J Lewin; Vaughan J Carr; Jim Sheedy; Anthony W Harris
Journal:  Schizophr Res       Date:  2006-10-17       Impact factor: 4.939

2.  Correlates of competitive versus noncompetitive employment among adults with psychotic disorders.

Authors:  Geoffrey Waghorn; Sukankta Saha; John J McGrath
Journal:  Psychiatr Serv       Date:  2014-04-01       Impact factor: 3.084

3.  Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity.

Authors:  J M Gold; C Queern; V N Iannone; R W Buchanan
Journal:  Am J Psychiatry       Date:  1999-12       Impact factor: 18.112

Review 4.  Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.

Authors:  Michael F Green
Journal:  J Clin Psychiatry       Date:  2006       Impact factor: 4.384

5.  Demographic characteristics and employment among people with severe mental illness in a multisite study.

Authors:  Jane K Burke-Miller; Judith A Cook; Dennis D Grey; Lisa A Razzano; Crystal R Blyler; H Stephen Leff; Paul B Gold; Richard W Goldberg; Kim T Mueser; William L Cook; Sue K Hoppe; Michelle Stewart; Laura Blankertz; Kenn Dudek; Amanda L Taylor; Martha Ann Carey
Journal:  Community Ment Health J       Date:  2006-04

6.  Use of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) to investigate group and gender differences in schizophrenia and bipolar disorder.

Authors:  Andrea Gogos; Nicole Joshua; Susan L Rossell
Journal:  Aust N Z J Psychiatry       Date:  2010-03       Impact factor: 5.744

7.  [Development and validation of the Social Functioning Scale, short version, in schizophrenia for its use in the clinical practice].

Authors:  J Alonso; Jm Olivares; A Ciudad; J Manresa; A Casado; I Gilaberte
Journal:  Actas Esp Psiquiatr       Date:  2008 Mar-Apr       Impact factor: 1.196

8.  The impact of supported employment and working on clinical and social functioning: results of an international study of individual placement and support.

Authors:  Tom Burns; Jocelyn Catty; Sarah White; Thomas Becker; Marsha Koletsi; Angelo Fioritti; Wulf Rössler; Toma Tomov; Jooske van Busschbach; Durk Wiersma; Christoph Lauber
Journal:  Schizophr Bull       Date:  2008-04-09       Impact factor: 9.306

9.  The effectiveness of supported employment for people with severe mental illness: a randomised controlled trial.

Authors:  Tom Burns; Jocelyn Catty; Thomas Becker; Robert E Drake; Angelo Fioritti; Martin Knapp; Christoph Lauber; Wulf Rössler; Toma Tomov; Jooske van Busschbach; Sarah White; Durk Wiersma
Journal:  Lancet       Date:  2007-09-29       Impact factor: 79.321

10.  Gainful employment reduces stigma toward people recovering from schizophrenia.

Authors:  David V Perkins; Joshua A Raines; Molly K Tschopp; Todd C Warner
Journal:  Community Ment Health J       Date:  2008-07-24
View more
  5 in total

1.  Long-Acting Injectable Antipsychotics: Analysis of Prescription Patterns and Patient Characteristics in Mental Health from a Spanish Real-World Study.

Authors:  Juan Antonio García-Carmona; Jorge Simal-Aguado; María Pilar Campos-Navarro; Francisco Valdivia-Muñoz; Alejandro Galindo-Tovar
Journal:  Clin Drug Investig       Date:  2020-05       Impact factor: 2.859

2.  Does Employment Promote Recovery? Meanings from Work Experience in People Diagnosed with Serious Mental Illness.

Authors:  Javier Saavedra; Marcelino López; Sergio Gonzáles; Rosario Cubero
Journal:  Cult Med Psychiatry       Date:  2016-09

3.  Knowledge of Prevention Measures and Information About Coronavirus in Romanian Male Patients with Severe Mental Illness and Severe Alcohol Use Disorder.

Authors:  Valentin Matei; Alexandru Pavel; Ana Giurgiuca; Alina Roșca; Arina Sofia; Irina Duțu; Cătălina Tudose
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-26       Impact factor: 2.570

Review 4.  Barriers to and facilitators of employment for people with psychiatric disabilities in Africa: a scoping review.

Authors:  I D Ebuenyi; E V Syurina; J F G Bunders; B J Regeer
Journal:  Glob Health Action       Date:  2018       Impact factor: 2.640

5.  Neurocognitive Impairment in Severe Mental Illness. Comparative study with Spanish Speaking Patients.

Authors:  Gabriel G De la Torre; Sandra Doval; David López-Sanz; Manuel García-Sedeño; Miguel A Ramallo; Macarena Bernal; Sara González-Torre
Journal:  Brain Sci       Date:  2021-03-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.